Chemed (CHE) PT Raised to $436 at RBC Capital
RBC Capital analyst Ben Hendrix raised the price target on Chemed (NYSE: CHE) to $436.00 (from $422.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
